SAFETY, TOLERABILITY AND PHARMACOKINETIC OF GIC-1001 FOLLOWING MULTIPLE ASCENDING DOSES ADMINISTRATIONS THROUGH AN ADAPTIVE FIRST IN HUMAN STUDY IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Paquette, J. M. [1 ]
Rufiange, M. [1 ]
Sadoune, A. Ait [1 ]
Sicard, E. [1 ]
Massicotte, J. [1 ]
Lefebvre, M. [1 ]
Colin, P. [2 ]
Ranger, M. [2 ]
机构：
[1] Algorithme Pharma, Laval, PQ, Canada
[2] gIcare Pharma Inc, Montreal, PQ, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2014年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S61 / S61
页数：1
相关论文
共 50 条
  • [31] Safety, tolerability and pharmacokinetic profile of Macozinone (PBTZ169) formulated as native crystal powder: multiple ascending-doses, phase-Ib trial in healthy volunteers
    Chtioui, H.
    Prod'Hom, S.
    Desfontaine, V
    Andre, P.
    Moulfi, F.
    Bardinet, C.
    Abo-Loha, C.
    Tessieras, J.
    Rothuizen, L.
    Diezi, L.
    Guidi, M.
    Ivanyuk, A.
    Decosterd, L.
    Cole, S.
    Buclin, T.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S7 - S8
  • [32] A first-in-human study of Brozopentyl Sodium, following single and multiple ascending intravenous infusion in Chinese healthy volunteers
    Sheng, Xiao-yan
    Xie, Ran
    Wei, Lu-hua
    Jia, Bo
    Li, Yun-feng
    Zheng, Zhi-guo
    Zhao, Xia
    Cui, Yi-min
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [33] A randomized, double-blind, placebo-controlled, first-in-human single ascending dose, multiple ascending dose, and food effect study to evaluate the safety, tolerability, and pharmacokinetic profile of FM101 in healthy volunteers
    Ha, Seon-Ah
    Kim, Mi Ri
    Kang, Saehan
    Yu, Mira
    Park, Chong-Woo
    Lee, Jiyoun
    Kang, Jiyeon
    Kim, Ji-Young
    Seo, Seong Wook
    Son, Seohyun
    Cho, Hyeon Deok
    Lee, Hyuk Woo
    Jeong, Lak Shin
    JOURNAL OF HEPATOLOGY, 2020, 73 : S446 - S447
  • [34] Safety, tolerability, pharmacokinetic profile and pharmacodynamic characteristics of sabiporide, a novel cardioselective NHE-inhibitor, after oral and IV single doses in healthy male volunteers.
    Klueglich, M
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Rathgen, K
    Nehmiz, G
    Trommeshauser, D
    Seidler, R
    Roberts, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1056 - 1056
  • [35] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
  • [36] The pharmacodynamic and pharmacokinetic profile, safety and tolerability of the new H1 anti-histamine, vapitadine (R129160; hivenyl™), after single and multiple oral doses in healthy volunteers.
    Beetens, J.
    Leempoels, J.
    Van Osselaer, N.
    Van Peer, A.
    Vande-Plassche, L.
    Cauwenbergh, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A78 - A78
  • [37] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF MULTIPLE ASCENDING DOSES OF ELX-02 IN HEALTHY VOLUNTEERS, A POTENTIAL TREATMENT FOR CYSTIC FIBROSIS CAUSED BY NONSENSE MUTATIONS
    Leubitz, A.
    Sharpe, N. A.
    Maier, G.
    Banks, K.
    van Duzer, J.
    Campbell, K.
    Vanhoutte, F.
    Williams, G.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S340 - S340
  • [38] Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers
    Liang, Beibei
    Wang, Jin
    Bai, Nan
    Chi, Yulong
    Wang, Rui
    Cai, Yun
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1184 - 1190
  • [39] Safety, Tolerability, and Pharmacokinetic Profile of Single and Multiple Ascending Doses of GB5121, a CNS-Penetrant BTK Inhibitor, in Healthy Subjects
    Kirby, Brian J.
    Aranda, Richard
    Ward, Renee
    Steinberg, Marcos W.
    Hernandez, Maria
    Sosa, Judith
    Cravets, Matt
    Rose, Mark J.
    Osterhout, Robin
    Ding, Zhaoqing
    Yusuf, Isharat
    Fox, Judith
    Mathias, Anita
    BLOOD, 2022, 140 : 11570 - 11571
  • [40] A tolerability, safety and pharmacokinetic study of single and multiple oral doses of novel D3 partial agonist RGH-790 in healthy male volunteers
    Nagy, K.
    Laszlovszky, I.
    Markus, Z.
    Nemeth, G.
    Magyar, G.
    Juhasz, Z.
    Kapas, M.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S208 - S208
12345